METTL9

Chr 16

methyltransferase 9, His-X-His N1(pi)-histidine

Also known as: CGI-81, DREV, DREV1, PAP1, hMETTL9

The protein is a methyltransferase that catalyzes 1-methylhistidine modification of target proteins containing His-x-His motifs, which may affect metal binding properties of these proteins. Mutations cause autosomal recessive intellectual disability with microcephaly and seizures, typically manifesting in early childhood. The gene shows high constraint against loss-of-function variants (pLI = 0.80, LOEUF = 0.45), suggesting intolerance to heterozygous protein loss.

OMIMResearchSummary from RefSeq, UniProt
LOEUF 0.45
Clinical SummaryMETTL9
Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.80) — some intolerance to loss-of-function variants.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.45LOEUF
pLI 0.804
Z-score 2.99
OE 0.14 (0.060.45)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
2.62Z-score
OE missense 0.41 (0.340.51)
65 obs / 157.5 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios
LoF OE0.14 (0.060.45)
00.351.4
Missense OE0.41 (0.340.51)
00.61.4
Synonymous OE1.08
01.21.6
LoF obs/exp: 2 / 14.1Missense obs/exp: 65 / 157.5Syn Z: -0.50

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

METTL9 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 3 results · since 2015Search PubMed ↗
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC